NEWS & EVENTS

04/12/2019

OncoHost Opens First-of-its-Kind Proteomics Laboratory for Host Response Analysis for Cancer Therapy

Sharon, MD, CEO of OncoHost. "By combining OncoHost's proprietary technology with proteomic analysis, we are able to predict how individual patients may respond to treatment. This is the first step towards developing successful personalized cancer treatment plans." OncoHost has launched an extensive

Read More>
Cision

21/01/2020

OncoHost and RayBiotech Awarded $1 Million Grant From the BIRD Foundation to Advance Precision Oncology for Patients Receiving Immunotherapy

cancer patients." "The grant and support from the BIRD Foundation represents an important milestone for OncoHost," said Dr. Ofer Sharon, CEO of OncoHost. "We are committed to develop a system for the early identification of resistance to cancer therapy in patients

Read More>
Cision

21/01/2020

BIRD – Israel-U.S. Binational Industrial R&D Foundation to Invest $8 million in 9 New Projects

Boise, ID) to develop a cyber security solution to prevent and monitor persistent attacks on connected media devices. OncoHost (Binyamina, Israel) and RayBiotech Life (Peachtree Corners, GA) to develop

Read More>
Cision

14/05/2020

OncoHost to Present Data on Host Response Profiling for Melanoma Patients at 2020 ASCO Annual Meeting

patients. ASCO's annual meeting is taking place from May 29-June 2 online due to COVID-19. About OncoHost OncoHost combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of

Read More>
Cision